IV levetiracetam in the management of non-convulsive status epilepticus

被引:29
作者
Farooq, Muhammad U.
Naravetla, Bharath
Majid, Arshad
Gupta, Rishi
Pysh, Joseph J.
Kassab, Mounzer Y.
机构
[1] Michigan State Univ, Ctr Clin, Dept Neurol & Ophthalmol, Lansing, MI 48824 USA
[2] Sparrow Hlthcare Syst, Lansing, MI USA
关键词
intravenous levetiracetam; non-convulsive status epilepticus;
D O I
10.1007/s12028-007-0022-z
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction Status epilepticus (SE) is a medical emergency requiring prompt treatment to try to limit mortality and improve outcome. So far, newer antiepileptic drugs (AED) have not assumed a noticeable role in the treatment of SE. This may be in part due to the lack of IV forms for the newer AEDs. The IV form of Levetiracetam (IV-LEV) has recently become available and has a potential role in the treatment of SE. Methods and results We report two cases of non-convulsive SE that responded favorably to IV-LEV. The first patient is an 83-year-old male with a history of complex partial seizure disorder who presented with impaired consciousness. The second patient is an 82-year-old male with history of old left middle cerebral artery ischemic infarction, who presented with confusion. Both patients were found to have a non-convulsive status epilepticus on electroencephalography (EEG) and treated with IV-LEV. In both cases, electrographic SE stopped with marked clinical improvement. Both patients tolerated the medication well and no significant side effects occurred. Conclusion IV-LEV may have a potential role in the treatment of non-convulsive status epileptics.
引用
收藏
页码:36 / 39
页数:4
相关论文
共 7 条
[1]  
Dedeurwaerdere S, 2006, ACTA NEUROL BELG, V106, P91
[2]   Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein [J].
Gillard, M ;
Chatelain, P ;
Fuks, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 536 (1-2) :102-108
[3]  
Löscher W, 1998, J PHARMACOL EXP THER, V284, P474
[4]   The use of levetiracetam in refractory status epilepticus [J].
Patel, NC ;
Landan, IR ;
Levin, J ;
Szaflarski, J ;
Wilner, AN .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2006, 15 (03) :137-141
[5]   Levetiracetam intravenous infusion: A randomized, placebo-controlled safety and pharmacokinetic study [J].
Ramael, Steven ;
Daoust, Agnes ;
Otoul, Christian ;
Toublanc, Nathalie ;
Troenaru, Mona ;
Lu, Zhihong ;
Stockis, Armel .
EPILEPSIA, 2006, 47 (07) :1128-1135
[6]   Levetiracetam in the treatment of status epilepticus in adults: A study of 13 episodes [J].
Rossetti, AO ;
Bromfield, EB .
EUROPEAN NEUROLOGY, 2005, 54 (01) :34-38
[7]  
RUPPRECHT S, 2006, EPILEPSY RES